NeoPharm Co (XKRX:092730) Total Liabilities : ₩17,433 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Total Liabilities?

NeoPharm Co's Total Liabilities for the quarter that ended in Dec. 2023 was ₩17,433 Mil.

NeoPharm Co's quarterly Total Liabilities increased from Jun. 2023 (₩12,599.63 Mil) to Sep. 2023 (₩15,253.62 Mil) and increased from Sep. 2023 (₩15,253.62 Mil) to Dec. 2023 (₩17,432.57 Mil).

NeoPharm Co's annual Total Liabilities increased from Dec. 2021 (₩13,103.10 Mil) to Dec. 2022 (₩13,136.62 Mil) and increased from Dec. 2022 (₩13,136.62 Mil) to Dec. 2023 (₩17,432.57 Mil).

NeoPharm Co Total Liabilities Historical Data

The historical data trend for NeoPharm Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Total Liabilities Chart

NeoPharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

17,048.92

15,260.22

13,103.10

13,136.62

17,432.57

NeoPharm Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															13,136.62	18,877.43	12,599.63	15,253.62	17,432.57

NeoPharm Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

NeoPharm Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16944.787	+	(430.046	+	57.731999999998
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	17,433

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	177458.519	-	160025.954
	=	17,433

NeoPharm Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16944.787	+	(430.046	+	57.731999999998
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	17,433

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	177458.519	-	160025.954
	=	17,433

NeoPharm Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co (XKRX:092730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines